On Aug. 27, 2026, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) approved Bixlenvo™ (bictegravir…
On Jul. 24, 2026, Merck announced it has signed seven voluntary licensing agreements with generic drug manufacturers to…
On Dec. 18, 2025, the World Health Organization (WHO) announced it has validated Brazil for the elimination of…
On Oct. 7, 2025, the World Health Organization (WHO) launched the Global Clinical Trials Forum (GCTF), a global,…
On Sept. 24, 2025, Indian drugmakers Dr Reddy’s Laboratories and Hetero Labs announced they will sell generic versions…
On Jul. 14, 2025, The World Health Organization (WHO) released new guidelines recommending the use of injectable lenacapavir…
On Jun. 18, 2025, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo®…
On May 8, 2025, Bill Gates announced that he has decided to give away his money back to…
On Feb. 5, 2025, the proposed dismantling of the U.S. Agency for International Development (USAID) could disrupt clinical…
On Nov. 26, 2024, the the United Nations reported that fewer people contracted HIV last year than at…
On Jul. 25, 2024, the World Health Organization (WHO) announced during the 25th International AIDS Conference, being held…
On Jul. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $50.1 million to fund clinical-stage research…
On Apr. 11, 2023, a National Institutes of Health (NIH) clinical trial was stopped early because a daily…
On Sept. 21, 2022, during United Nations General Assembly week, the Bill & Melinda Gates Foundation—alongside governments, philanthropies,…
On Jul. 28, 2022, the World Health Organization (WHO) released new guidelines for the use of long-acting injectable…
On May 18, 2022, Moderna and the nonprofit scientific research organization IAVI announced that the first participant screenings…
On Apr. 7, 2022, Moderna and IAVI announced a collaboration to employ mRNA technology to meet the challenge…
On Jul. 22, 2021, the National Institutes of Health announced it had renewed grants to seven regional centers…
On Mar. 25, 2021, about two decades after first devising a new kind of vaccine, Oregon Health &…
On Nov. 18, 2020, Gilead Sciences announced topline results from the Phase 2/3 CAPELLA trial evaluating the company’s…
On Sept. 2, 2020, less than three weeks after getting on an organ transplant list for HIV-positive patients,…
On Aug. 11, 2020, Gilead Sciences announced that the China National Medical Products Administration (NMPA) had approved a…
On Jul. 7, 2020, a pre-exposure prophylaxis (PrEP) regimen containing an investigational long-acting form of the HIV drug…
On Jul. 6, 2020, Merck announced new analyses from the Phase 2b trial (NCT03272347) evaluating the safety and…
On Jul. 6, 2020, seventy-three countries warned that they were at risk of stock-outs of antiretroviral (ARV) medicines…
On Jul. 2, 2020, the U.S. Food and Drug Administration (FDA) approved Rukobia (fostemsavir), a new type of…
On Jul. 2, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the US Food…
On June 12, 2020, the U.S. Food and Drug Administration (FDA) approved Tivicay (dolutegravir) tablets and Tivicay PD…
On Jun. 12, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the FDA had…
On Jun. 11, 2020, researchers have found that astrocytes, a type of brain cell can harbor HIV and…